300168.SZ
300168.SZ
CNE100000ZD6
WONDERS INFORMATION
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 10/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).

Beta (Market Relation)
0.46x
Defensive
Volatility (5Y p.a.)
51.6% p.a.
5-Year Horizon
Max Drawdown (5Y)
-72.0%
5-Year Horizon
Sharpe Ratio
-0.38
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -29.7%
3 Years 53.3% -55.4% -0.42 -20.1%
5 Years 51.6% -72.0% -0.38 -17%
10 Years 50.0% -84.9% -0.33 -14.1%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 290%.
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (51.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -84.9% in the extended horizon.
ende